PAYLESS COMPOUNDERS, LLC 2026-04-22 Health serious FDA
Health · FDA · Recall #FDA-D-0471-2026
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx… Recall
Issued April 22, 2026 · PAYLESS COMPOUNDERS, LLC
In April 2026, PAYLESS COMPOUNDERS, LLC recalled the Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact PAYLESS COMPOUNDERS, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- PAYLESS COMPOUNDERS, LLC
- Category
- Health
- Recall date
- April 22, 2026
- Units affected
- Not reported
- Sold at
- OR
- Recall number
- FDA-D-0471-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- PAYLESS COMPOUNDERS, LLC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.